Listado de ensayos

Investigación


Categorías ensayos

Study of Docosahexaenoic Acid (DHA) Supplementation in Patients With X-Linked Retinitis Pigmentosa

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA

Tratamiento

Drug: docosahexaenoic acid
Ver informe

Natural History Study of Patients With X-linked Retinal Dystrophy Associated With Mutations in Retinitis Pigmentosa GTPase Regulator (RPGR)

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA

Localizaciones

Shiley Eye Institute - UCSD, La Jolla, California, United States Emory Eye Centre, Atlanta, Georgia, United States Massachusetts Eye and Ear Infirmary, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States UPMC Eye Centre, Pittsburgh, Pennsylvania, United States The Hospital for Sick Children, Toronto, Canada Moorfields Eye Hospital, London, United Kingdom
Ver informe

Follow-up Gene Therapy Trial for the Treatment of X-linked Retinitis Pigmentosa Associated With Variants in the RPGR Gene

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: Genetic: AAV5-RPGR 4e11 Biological: Genetic: AAV5-RPGR 2e11

Localizaciones

Vitreo Retinal Associates, Gainesville, Florida, United States The Emory Eye Centre, Atlanta, Georgia, United States Boston Eye and Ear, Boston, Massachusetts, United States Univeristy of Michigan, Ann Arbor, Michigan, United States Retinal Consultants of Houston, Bellaire, Texas, United States
Ver informe

A Clinical Trial Evaluating the Safety and Efficacy of a Single Subretinal Injection of AGTC-501 in Participants With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: rAAV2tYF-GRK1-hRPGRco
Ver informe

Clinical Evaluation of Patients With X-linked RETINOSIS PIGMENTARIA (XLRP)

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Localizaciones

Duke Eye Center, Duke University Medical Center, Durham, North Carolina, United States Casey Eye Institute, Oregon Health and Sciences University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States
Ver informe

Gene Therapy for X-linked Retinitis Pigmentosa (XLRP) Retinitis Pigmentosa GTPase Regulator (RPGR)

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Genetic: AAV2/5-RPGR

Localizaciones

Massachusetts Eye and Ear Institute, Boston, Massachusetts, United States Kellogg Eye Center, Ann Arbor, Michigan, United States UPMC Eye Center, Pittsburgh, Pennsylvania, United States Leeds Teaching Hospitals NHS Trust, Leeds, United Kingdom Moorfields Eye Hospital NHS Foundation Trust, London, United Kingdom
Ver informe

A Clinical Trial of Retinal Gene Therapy for X-linked RETINOSIS PIGMENTARIA Using BIIB112

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Portland, Oregon, United States Research Site, Philadelphia, Pennsylvania, United States Research Site, Dallas, Texas, United States Research Site, Manchester, United Kingdom Research Site, Oxford, United Kingdom Research Site, Southampton, United Kingdom
Ver informe

Safety and Efficacy of rAAV2tYF-GRK1-RPGR in Subjects With X-linked Retinitis Pigmentosa Caused by RPGR Mutations

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: rAAV2tYF-GRK1-RPGR

Localizaciones

University of Florida, Jacksonville, Florida, United States Columbia University, New York, New York, United States Duke Eye Center, Durham, North Carolina, United States Cincinnati Eye Institute, Cincinnati, Ohio, United States Casey Eye Institute, Oregon Health and Science University, Portland, Oregon, United States Retina Foundation of the Southwest, Dallas, Texas, United States
Ver informe

Long-term Safety and Efficacy Follow-up of BIIB111 for the Treatment of Choroideremia and BIIB112 for the Treatment of X-Linked Retinitis Pigmentosa

Estado: | Categoría: | Resultado:

Patología

Choroideremia RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Genetic: BIIB111 Genetic: BIIB112

Localizaciones

Research Site, Gainesville, Florida, United States Research Site, Miami, Florida, United States Research Site, Cincinnati, Ohio, United States Research Site, Portland, Oregon, United States Research Site, Dallas, Texas, United States Research Site, Madison, Wisconsin, United States Research Site, Edmonton, Alberta, Canada Research Site, Helsinki, Finland Research Site, Bonn, Germany Research Site, T bingen, Germany Research Site, Oxford, United Kingdom
Ver informe

Long Term Follow-Up Gene Therapy Study for XLRP RPGR

Estado: | Categoría: | Resultado:

Patología

RETINOSIS PIGMENTARIA LIGADA A X

Tratamiento

Biological: AAV-RPGR

Localizaciones

Moorfields Eye Hospital, London, United Kingdom
Ver informe